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A metabolic engineering perspective which views recombinant protein expression as a multistep pathway allows us
to move beyond vector design and identify the downstream rate limiting steps in expression. In E.coli these are
typically at the translational level and the supply of precursors in the form of energy, amino acids and nucleotides.
Further recombinant protein production triggers a global cellular stress response which feedback inhibits both
growth and product formation. Countering this requires a system level analysis followed by a rational host cell
engineering to sustain expression for longer time periods. Another strategy to increase protein yields could be to
divert the metabolic flux away from biomass formation and towards recombinant protein production. This would
require a growth stoppage mechanism which does not affect the metabolic activity of the cell or the transcriptional
or translational efficiencies. Finally cells have to be designed for efficient export to prevent buildup of proteins
inside the cytoplasm and also simplify downstream processing. The rational and the high throughput strategies
that can be used for the construction of such improved host cell platforms for recombinant protein expression is
the focus of this review.
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Host cell engineering has emerged as a powerful tool for
designing microbial platforms targeted at improved me-
tabolite production. Major successes in this area include
improved production of isoprenoids, shikimic acid, iso-
butanol, amino acids, synthesis of artemesin, lycopene
and many such metabolites [1-7]. The basic goal has
been to redesign the complete pathway for the biosyn-
thesis of these metabolites by simultaneously engineering
multiple steps in the pathway. This has been achieved by a
combination of many techniques such as gene knock-ins
and knock-outs, promoter engineering, supplementing
the expression of critical genes, enzyme engineering
and modulation of the regulatory pathways. The com-
monly used strategies to enhance the metabolite flux
through a pathway can be clubbed under the follow-
ing categories a) Increase the flux through rate limit-
ing steps in the pathway; b) Increase the supply of
precursors; c) Block branched chain pathways which* Correspondence: kjmukherjee@mail.jnu.ac.in
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unless otherwise stated.lead to by-product formation and d) Remove feedback
controls in the pathway (Figure 1).
It is possible to extend the same philosophy with minor
modifications to help in the design of hosts with improved
recombinant protein expression capability. Just like the
pathways in metabolite synthesis, recombinant protein ex-
pression also involves multiple steps viz. transcription,
translation, folding and export. However unlike a typical
metabolic pathway these steps are intricately linked to the
cellular machinery with multiple host factors determining
the flux through each step of the pathway. Hence the cel-
lular physiology and its dynamics have a critical role in de-
termining the overall flux through this pathway. Some
important points that can be flagged by this approach are
summarized as follows; traditional genetic engineering
methods have mostly focused on improving the first step
of this pathway i.e. transcription and hence the gains from
improved vector design have tended to plateau over time.
With strong promoters, the bottleneck in this pathway
shifts to the translational step which needs to be up regu-
lated to match the rates of transcription. Otherwise much
of the gains of high rates of mRNA synthesis are offset by
higher rates of mRNA degradation [8-11]. The supply ofl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Metabolic engineering strategies to enhance the flux through a pathway. The various strategies used to improve the flux from a
cellular intermediate to the desired product is shown. This includes enhancing pathways leading to the formation of intermediates (shown in
yellow) and pathways which are rate limiting (B to C). Additionally branched chain pathways and feed back controls need to be blocked.
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ergy molecules like ATP, amino acids and nucleotides
which can become the rate limiting factors in protein bio-
synthesis. Most importantly recombinant protein expres-
sion triggers a cellular stress response which feedback
inhibits both growth and product formation, by lowering
substrate uptake rates, down-regulating the ribosomal ma-
chinery and biosynthesis of ATP (Figure 2). This has a
critical impact on the sustainability of the flux through
this pathway and typically specific product formation rates
decline sharply within a few hours post induction. Since
host cell protein synthesis utilizes the same cellular ma-
chinery it can be treated as a competing pathway. Thus
one way to increase recombinant protein synthesis would
be to uncouple growth from product formation, thus
allowing the diversion of metabolic fluxes toward product
formation. Finally an efficient export mechanism needsFigure 2 Simplified schematic of the cellular stress response on various
pathways are shown in green (substrate uptake, ribosomes, translation rates, tR
and stress response) are shown in red.to be in place, otherwise there is a theoretical upper
limit to which the recombinant protein can accumulate
inside the cells. Moreover extracellular expression would
significantly simplify downstream processing steps. The
challenges associated with designing such host platforms
using both rational as well as high throughput strategies is
the primary focus of this review.
Improving transcriptional efficiency
The first step in the pathway for recombinant protein
biosynthesis has possibly received the largest attention
in terms of improved vector design. A very wide range
of vectors are available both for E.coli and other mi-
crobes with specific features tailored for different applica-
tions [12-14]. The rate of mRNA synthesis is determined
by both gene copy number and promoter strength, how-
ever with strong promoters like the T7 and T5, plasmidfactors affecting recombinant protein synthesis. The down-regulated
NA and ATP) and up regulated pathways (Proteases, acetate formation
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ther the use of low copy number, stable vectors allows for
lowered levels of ‘leaky’ expression which is important
while expressing toxic proteins. Promoter design has thus
focused more on titratable and tightly regulated systems
rather than strength alone [15-18]. Thus a slow and con-
trolled expression which leads to a properly folded protein
can also be an important goal as is obtained with titratable
promoters using low inducer concentrations [19,20]. Add-
itionally the use of fusion tags in vector constructs can
serve multiple purposes, like efficient purification, im-
proved solubility, increased mRNA stability and more effi-
cient translation [21-27]. To further simplify the process
of protein production useful features like auto inducible
systems [28-31] and self-cleavable tags have been incorpo-
rated in vector design [32-34].
Removing translational bottlenecks
Translation has been identified as the rate controlling
step in recombinant protein synthesis for most high ex-
pression systems (Figure 3). Many factors have a role in
controlling translational efficiency including, the first
few codons of the mRNA to be translated (translation
initiation) and the mRNA secondary structure. The ribo-
somal binding site (RBS) secondary structure is highlyFigure 3 Cellular factors controlling the rate of translation. These facto
structure affecting the Translation Initiation Rates (TIR) and the UTR sequence
RNase over expression, c) Availability of charged tRNA which depends on ATP
translation and stability.important for efficient initiation of translation. Recombin-
ant protein translation in E.coli may be inhibited by pres-
ence of secondary structures in the RBS as well as 5’UTR
region. Computational tools like ‘ExEnSo’ (Expression
Enhancer Software) offer a platform where heterologous
gene sequences can be designed on the basis of highest
free energy so as to avoid translation inhibition due to
mRNA secondary structures. The software also creates a
5’ primer on the basis of the ‘optimized’ sequence which
can be used in PCR experiments to amplify the cod-
ing sequence of heterologous gene [35]. Similarly a
predictive method for designing synthetic ribosome
binding sites has been developed which enables a ra-
tional control over the protein expression level. This
work combines a biophysical model of translation ini-
tiation with an optimization algorithm to predict the
sequence of a synthetic RBS sequence that provides a
target translation initiation rate [36]. Another work
involving a random combinatorial DNA sequence li-
brary has revealed that not only the SD sequence but
the entire UTR sequence, seems to play an important role
in the translational process [37] implying that the rate of
translation can also be rate-limiting. Translation rate cal-
culators have been designed to estimate protein transla-
tion rates based on the sequence of the mRNA and havers which directly effect translation efficiency are a) mRNA RBS secondary
s, b) Degradation of ribosomes due to substrate non-availability and
supply and codon bias. Additionally global regulator like FIS also control
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protein expression [38].
The increase in utilization of the protein synthetic ma-
chinery upon induction leads to a degradation of the
ribosomal machinery, as a feedback stress response to
over expression [39,40] that ultimately leading to a loss
in the protein synthesis capacity. This decreased capacity
of cells to synthesize proteins, as part of the stringent re-
sponse, highlights the major challenges regarding the
sustainability of recombinant protein production. It has
been shown that whereas E.coli ribosomes are stable
during exponential growth and in the stationary phase,
degradation occurs between the transition stages and is
independent from the triggering effect of the alarmone
ppGpp(p) [41]. Degradation of stable RNA is also associ-
ated with conditions of starvation. Thus, depletion of
any one of a number of nutrients including phosphate
[42], nitrogen [43], carbon [44], or evenMg+2 [45] leads
to a dramatic loss of RNA. RNase expression is also trig-
gered during the stress response and can contribute to
degradation of stable RNA [46].
Rate of translation may also slow down due to non-
availability of aminoacylated transfer RNA (tRNA). The
availability of charged aminoacylated transfer RNA fur-
ther depends on codon composition of the transcript.
The rationale behind codon usage optimization is to
modify the rare codons in the target gene to mirror the
codon usage of the host [47,48]. It is also known that
the availability of tRNA varies significantly under differ-
ent growth and stress conditions, which facilitates cellu-
lar adaptation to translational dynamics across the genome.
Experimental measurements of tRNA concentrations and
their charged fractions under stressful conditions have
shown that tRNA availability can vary significantly between
conditions and over time [49,50]. A computational work-
flow for estimating codon translation rates based on tRNA
availability has been developed. This could be particularly
important when considering the over expression of a re-
combinant protein, where a specific codon composition
might lead to the depletion of certain charged tRNA
pools [51] or under amino acid limited growth condi-
tions that have been shown to lead to specific charging
patterns [52,53]. This deficiency may lead to amino acid
mis-incorporation and/or truncation of the polypeptide,
thus affecting the heterologous protein expression
levels and/or its activity [54]. OPTIMIZER, JCAT, Syn-
thetic Gene Designer, DNAWorks, GeneDesign, Codon
optimizer, GeMS are some of the online tools available
to optimize codon usage (reviewed in [55]).
Likewise there are models like Ribosomal Flow Model
(RFM) which analyses translation process on the basis of
its physical and dynamical nature [56]. It considers the
effect of codon order on translation rates, the stochastic
nature of the translation process and the interactionsbetween ribosomes while predicting the translation elong-
ation step. This approach gives more accurate predictions
of translation rates, protein abundance and ribosome dens-
ities in comparison to contemporary approaches. Another
interesting feature that might be useful for recombinant
protein expression and folding is the Translational
pause at a rare codon. This provides a time delay to en-
able independent and sequential folding of the defined
portions of the nascent polypeptide emerging from the
ribosome [57].
Additionally there are regulatory genes that control
the rates of ribosome biosynthesis. CsrA, is a posttran-
scriptional global regulator that regulates mRNA stabil-
ity and translation, which in turn is regulated by two
sRNAs csrB and csrC [58-60]. The E.coli DNA binding
protein Fis is a transcriptional modulator involved in
the regulation of many cellular processes, including the
activation of rRNA synthesis. High-level expression of fis
in early, mid, or late log cultures has been shown to re-
sult in growth phase and medium-specific variations in
cell growth, rRNA synthesis, and ribosome content [61].
Improving energy availability
The synthesis of recombinant proteins is energy intensive
and interferes with the host physiology [62]. The high
energy demand during recombinant protein production
leads to an enhanced need for ATP generation at the cost
of biomass formation [63]. This increases maintenance en-
ergy requirements which manifests itself as an increased
metabolic burden on the cells [64]. In order to sustain this
energy demand, cells take up alternative pathways like
substrate level phosphorylation leading to acetate forma-
tion by carbon overflow metabolism. As a consequence of
reduced biomass formation, excess NADPH might be con-
verted to NADH via the soluble transhydrogenase, filling
the electron transport chain for additional ATP gener-
ation. This hypothesis is supported by a positive correl-
ation between ATP production and productivity, while an
inverse correlation exists between biomass yield and prod-
uctivity. Although the ATP generation rate increases with
increasing demand, the TCA cycle activity remains con-
stant, indicating a limited capacity of the TCA cycle to
overcome the postulated metabolic burden [65].
It has been shown that protein synthesis consumes ap-
proximately two-thirds of the total energy produced by a
rapidly growing E.coli cell [66]. Consequently, much ef-
fort has been focused on understanding the mechanisms
of ATP and GTP usage during protein synthesis. It was
thus observed that phosphoenolpyruvate carboxykinase
(PCK) when expressed in E.coli under glycolytic condi-
tions helped in increasing the intracellular ATP levels,
leading to enhanced protein production, of both the
model proteins GFP (intracellular) and Alakaline Phos-
phatase (extracellular) [67]. Polymerization of amino acids
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tion of ATP to mediate amino acid-charged tRNA synthesis
[68]. It is known that the concentration of aminoacylated-
tRNA (charged tRNA) molecules is higher in rapidly grow-
ing bacteria, and it has been postulated that the availability
of the charged tRNA is one of the check points that deter-
mines the rate of protein translation [69].
Cofactor regeneration
Cofactors play an important role in generation of cor-
rectly folded, stable and functional recombinant proteins
[70]. Any imbalance in cofactor consumption and regen-
eration can lead to a severe reduction of growth. Since
these are the driving forces behind most anabolic path-
ways as well as oxidative phosphorylation, it is necessary
to design strategies to enhance cofactor regeneration.
OptSwap is a computational method which predicts strain
designs by identifying optimal modifications of the cofac-
tor binding specificities of oxidoreductase and comple-
mentary reaction knockouts [71]. Another mathematical
framework, cofactor modification analysis (CMA), is a
well-established constraints-based flux analysis method
for the systematic identification of suitable cofactor specifi-
city engineering (CSE) targets while exploring global meta-
bolic effects [72]. Several genetic strategies employed for
cofactor engineering have been reviewed earlier [73-76].
Facilitating protein folding and export
A major effort in recent years has focused on improved
protein folding in vivo using chaperone co-expression
[40,77-79]. These molecular chaperones essentially be-
long to Hsp70 chaperone family. Thus DnaK which is an
Hsp70 homolog binds to unfolded hydrophobic stretches
and helps protein folding while chaperones like GroEL
encapsulates the nascent polypeptide and prevents inter
molecular interactions [80]. A major issue is matching
the availability of chaperones with the rates of produc-
tion of the nascent polypeptide to prevent misfolding.
This is a problem when high level expression systems
are used. The only way to circumvent this is to have
lower but sustained rates of protein expression leading
to a slow buildup of the recombinant protein. Another
important aspect is providing an oxidizing environment
for correct disulfide bond formation in the cytoplasm or
catalyzing bond formation of the oxidized protein in the
periplasm [81]. This has been attempted by introducing
genes for formation of disulfide bonds. Thus strains cap-
able of producing properly folded proteins, even those
with multiple disulphide bonds, are now available [82-87].
An E.coli strain has recently been designed for protein
transport which oxidizes disulfide bonds in the cytoplasm
and then efficiently exports these disulfide containing pro-
teins using a signal peptide. These test proteins include al-
kaline phosphatase (PhoA), a phytase containing fourdisulfide bonds (AppA), an anti-interleukin 1bscFv and
human growth hormone [88].
The more challenging task is protein export not just
to the periplasm but to the extracellular medium. This
would not only greatly simplify purification but also re-
move the upper bound on the accumulation of proteins
in the culture. There are five pathways for protein secre-
tion in E.coli Type I, II, III, IV and V. However, only the
first and second secretion pathways are commonly used
in recombinant protein secretion. Type I pathway dir-
ectly targets proteins from cytoplasm to extracellular
medium [89,90]. Studies have shown that the Type II
Sec dependent pathway gets overloaded leading to an ac-
cumulation of unfolded proteins [91-95]. Plasmid based
over expression of SecY, SecE and SecG proteins, which
are the major interacting partners of SecA, resulted in a
strong enhancement of a) translocation ATPase activity,
b) preprotein translocation, c) capacity for SecA binding,
and d) formation of the membrane-inserted form of
SecA [96] (Figure 4). There are reports of a few proteins
which get naturally secreted into the medium [97-99].
Others like GFP which do not get secreted through the
Sec dependent pathway have been successfully exported
via a modified TAT dependent secretion pathway [100].
In another work synthetically designed lipase ABC trans-
porter domains (LARDs) from P.fluorescens lipase were
attached to GFP and epidermal growth factor (EGF).
The fused proteins were successfully secreted with the
ABC transporter and showed lipase activity as an intact
fused form in the supernatant [101]. These examples
highlight some of the important developments in this
area which has the potential of making E.coli into a truly
secretory protein expression system.
Feedback inhibition of product formation
It is well known that growth rates decline post induction
in most cultures. It was earlier postulated that this was
due to the ‘metabolic burden’ associated with the diver-
sion of metabolic fluxes towards recombinant protein
synthesis [102]. However a careful analysis of experi-
mental data shows that this rate of decline of growth
post induction, in the absence of substrate limitation is an
intrinsic property of the cell and specific to the protein be-
ing expressed [103]. Thus some proteins like γ –interferon
[104], α-interferon [105] even when they are expressed at
high levels do not adversely affect growth while others like
insulin [106], GMCSF [107,108], streptokinase [109], lead
to a complete growth stoppage post–induction. Interest-
ingly this retardation is also dependent on whether a pro-
tein is expressed as inclusion bodies or as a soluble protein
like GMCSF and streptokinase [110-112]. Therefore at-
tempts to explain growth retardation in terms of the amino
acid composition of the expressed protein has limited pre-
dictive value [51,113,114] though clearly different amino
Figure 4 Various pathways for protein translocation (Type I and II). The type II Sec-dependent pathway is the most commonly used and
gets overloaded leading to accumation of mis folded proteins in the cytoplasm. However the TAT dependent pathway is used for export of
folded proteins and thus requires proper folding in the cytoplasm itself.
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Clearly a static “diversion of fluxes” model is inadequate to
explain this growth retardation rather a complex cellular
dynamics controls both the growth and product formation
kinetics.
This phenomenon of growth retardation is better
understood by analyzing the cellular stress response to
recombinant protein expression, which characteristically
depends on the nature of protein, the form of expression
(whether soluble or inclusion bodies) and the level of ex-
pression (whether from a strong or weak promoter)
[115,116]. Moreover environmental factors such as the
medium composition (presence or absence of complex
nitrogen sources) [19,84,117,118] and the specific growth
rate may also effect the nature of this response [119,120].
Studies have shown that this stress response mimics the
features of the heat shock response, the oxidative stress re-
sponse and the stringent response [39,114,121]. There are
a set of common genes which get up or down-regulated
due to this response which belong to the substrate uptake,
amino acid and ribosomal biosynthesis genes and those
involved in energy metabolism [39,121]. Others which are
specific to the form of expression, like IB expression are
clpBP, dnaJK, groLS, grpE, hslRUV, htpGX, ibpAB, lon,
rlmE, rpoD, yrfI [122-124]. It is difficult to model this
stress response using systems biology tools like Flux Bal-
ance Analysis (FBA) to predict the changes in fluxes of
various pathways [125,126]. This is primarily because thecommonly used metabolic model of E.coli with the largest
set of pathways covers only ~30% of genes which are actu-
ally present in the organism [127,128]. Most of the differ-
entially expressed genes are not part of this metabolic
network and this unavailability prevents their expression
mapping and FBA analysis using the model. Thus the stress
response is better modeled as the triggering of key regula-
tory genes which in turn trigger a cascade of other down-
stream genes [121]. Efforts have been made to develop
regulatory models which can analyze the complex interplay
of the regulatory and metabolic networks [129-132]. These
models could be applied in the analysis of the stress re-
sponse due to recombinant protein over expression and
provide us with leads for designing improved expression
platforms. However there are as of now very few pub-
lished reports on attempting to modulate this stress
response by gene knock-ins or knock-outs. One would
expect that knock-out of non-essential genes which get
up-regulated due to the stress response or conversely sup-
plementing gene expression of the down-regulated genes
may help alleviate this stress and have a beneficial effect on
recombinant protein expression [133,134].
The use of metabolic engineering strategies to remove
the bottlenecks in recombinant protein production iden-
tified by analyzing this stress response has helped in im-
proving the supply of precursors like NADPH, modification
of global stress regulators and increasing the flux of the
down regulated metabolic pathways including that of
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by over expressing the glpK gene, lead to a 35% higher
rhIFN-β expression as compared to control cultures [133].
The issue of acetate formation has been solved by knock-
ing out genes (ackA, pta, ppc and poxB) in the acetate
biosynthesis pathway leading to improve the recom-
binant protein production [135,138,140]. Supplementa-
tion of down regulated genes either through plasmid
based expression or chromosomal integration have been
successfully tried, e.g. Expression of the zwf gene coding
for glucose-6-phopshate dehydrogenase in the Pentose
Phosphate pathway helps to provide building blocks like
nucleotides and NADPH and thus improves recombinant
protein expression [139]. Knock out of ppGpp as well as
the deletion of the global regulator rpoS (which is trig-
gered by ppGpp) has been shown to enhance the recom-
binant protein expression [141-144]. The metabolic
engineering strategies to improve the E.coli phenotype for
recombinant protein production has also been reviewed
earlier [145].
Uncoupling growth from product formation
The growth associated nature of recombinant protein
production means that high specific growth rates need
to be maintained in order to get high specific product
formation rates. Since product concentration in a bio-
reactor is determined both by biomass concentration
and specific product yield, we have the twin require-
ments of growing cells to high cell densities while simul-
taneously maintaining high specific growth rates. Together
these requirements usually lead to oxygen or heat transfer
limitations in the bioreactor especially during scale up.
Hence the ability to produce product at high rates using
slow growing or non-growing cells could greatly simplify
the bioprocess strategy for high level product formation.
Secondary metabolites are a very good example of how the
non-growth associated nature of product formation kinet-
ics allows the easy separation of growth and product for-
mation phases in a bioreactor. In the case of recombinant
protein synthesis, we need to ensure that the resting cells
are metabolically active in terms of substrate uptake and
energy metabolism as well as transcription and translation.
One interesting development in this regard was the Qui-
escent cell expression system where growth and product
formation kinetics were decoupled [146]. Growth stop-
page was achieved by over expressing a small RNA ‘Rcd’
which blocks cell division. However recombinant protein
expression is unimpaired, and since the translational ma-
chinery is not required for biosynthesis, these cells have a
significantly higher productivity compared to normally
growing cells [147]. Further studies on the mechanism of
Rcd showed that it binds to tryptophanase leading to the
overproduction of indole [148]. Thus an exogenous supply
of indole was also able to block cell division withoutaffecting recombinant protein expression. However indole
targets multiple sites in the cell [149-151] and may not be
a preferred option for recombinant protein expression.
Therefore targets downstream of indole which specifically
blocks cell growth without affecting metabolic activity
needs to be identified in order to achieve improved
quiescence.Tools for host cell engineering
This section deals with the vast array of techniques that
have now become available, greatly simplifying the task
of host modification to obtain the desirable phenotype
by rational or high throughput approaches.Single gene modification strategies
While the use of plasmid based methods for supple-
menting gene expression may be useful in ‘proof of
principle’ studies, they have severe limitations. There is
an upper limit to the number of target genes that can be
supplemented; also the level of supplementation may be
far higher than desired, leading to an unnecessary meta-
bolic burden on the cells. Thus chromosomal engineer-
ing which leads to the construction of plasmid-less,
marker-less strains has the advantage of extending the
practical exploitation of the modified hosts in industry
[152]. Also promoter engineering allows us to fine tune
the expression of genes to desired levels [153,154]. One
of the earliest strategies to design Single-gene knockouts
was using the λ RED-ET system. Here the gene to be
knocked out is replaced with an antibiotic resistance
gene, usually kanamycin or chloramphenicol. If required,
the selection marker can be removed by expressing the
Cre or FLP recombinases that acts on the FRT or loxP
site that is present in the flanking region of the selection
marker or antibiotic cassette [155-161]. Another com-
monly used method for Single-gene knockouts is the
P1-mediated transduction [162-166]. This method has
gained popularity because of the availability of the Keio
library of single gene knock-outs of non-essential genes
in BW25113 which can be easily transferred into almost
any E.coli strain [167]. Many researches prefer to use the
vector plasmid pKO3 which integrates into the chromo-
some by homologous recombination creating tandem
duplication at the non-permissive temperature. When
shifted to the permissive temperature, the presence of
the pSC101 replication origin in the vector ensures that
it is excised from the chromosome. The presence of the
sacB gene from B.subtilis in the vector allows us to
screen for the loss of the vector sequence by growing
the cells in the presence of sucrose [168].
The main limitation of these techniques is that they
can be applied for single gene modifications and if mul-
tiple knock-ins and knock-outs have to be done, then
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manner.
High throughput genome engineering methods
High throughput methods have been developed for gen-
ome engineering like Multiplex automated genome en-
gineering (MAGE), Trackable multiplex recombineering
(TRMR) and use of small regulatory RNAs [169-172].
These methods can create simultaneous random com-
binatorial modifications in the E.coli genome. Till now
these approaches have mainly been used for evolutionary
studies and pathway optimizations in E.coli. The same
strategy can be applied for improving recombinant protein
expression. As MAGE, works through oligonucleotide-
mediated allelic replacement in an iterative manner it is
capable of introducing multiple modifications in different
locations of genome. Therefore several oligomers can be
designed to perform multiple modifications iteratively,
which can help in identifying the combinations which lead
to the desired phenotype including that of enhanced pro-
tein capability (Figure 5). Recently, a group led by Y.S.
Ryu, has modified MAGE so that it is not restricted to
EcNR2 strains of E.coli [160]. This is important since it is
well known that there is a wide variation in the expression
levels obtained with different E.coli strains [173]. AlsoFigure 5 Overall Strategy for host cell engineering using rational and
physiology and Omics studies can be used to identify system level bottlen
high throughput methods to generate improved platforms for expression.
clones for further scale-up.strains carrying different modifications and having the de-
sired phenotype can be combined in a step wise fashion
using Conjugative assembly genome engineering (CAGE)
[174,175]. This approach can be used to look for synergy
between various modifications. The major drawback with
MAGE is that it also accumulates unwanted off-target
mutations [175] and thus a method for genome engineer-
ing at multiple locations with greater precision needs to
be developed [176]. Another method for rapid modifica-
tion of many genes in E.coli is TRMR. This technique uses
a large number of synDNAs with multiple desirable
sequence features, to modulate the expression levels of
genes. The synDNA contains different RBS which replaces
the native RBS and a Molecular barcode is used to track
the allele in mixed populations [177]. Another novel ap-
proach for high throughput metabolic engineering is the
use of a transcriptional vector to express small chro-
mosomal DNA fragments of E.coli itself. Since some frag-
ments get inserted in the opposite orientation, they act as
an anti-sense RNA and create a library of down-regulated
pathways which can be screened for improved recombin-
ant protein expression [178]. This has been extended to
the use of synthetic Small regulatory RNAs (sRNAs)
which helps in the modulation of gene expression [169].
This method is useful when we need to down regulatehigh throughput methods. Leads obtained from analysis of cellular
ecks. These can be addressed by both single gene modifications or
These are initially tested in microbioreactor format to select the best
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gene, making it an indispensable tool for studying the ef-
fect of essential genes on cellular phenotype.
High throughput screening strategies
The screening of a large number of gene knock-in and
knock-outs to select the desirable phenotype of improved
expression capability is time consuming. The simplest ap-
proach to screen a very large number of clones is to use
FACS based screening for cells expressing fluorescence
tagged proteins like GFP [179,180]. Thus libraries with
engineered genomes can be screened for the highest pro-
ducers by using appropriate sorting protocols [181,182].
However such modified hosts may not necessarily over
express other proteins, given the very specific nature of
host-protein interactions. Another strategy would be the
selection of quiescent phenotype, in order to uncouple
growth and product formation. For this one can screen
for a growth stoppage phenotype which typically leads to
elongated cell morphologies due to stoppage of cell div-
ision [183]. Simultaneously or later these cells can be
checked for recombinant protein expression capability after
growth arrest. Such techniques can be coupled with auto-
mated devices where cultures can grow in 96 well plate for-
mats. Such technologies have proven to work well in clone
screening and help in quickly identifying the best per-
formers from a large number of clones e.g. BioLector from
m2p Labs [184,185], Bioscreen C from Oy Growth Curves
Ab Ltd [186-190], Clone Screener from Biospectra AG and
the Ambr reactor from TAPBiosystems. Apart from growth
profiling, these systems can also do online monitoring of
fluorescence, pH, dissolved oxygen and NADH [185] and
are reviewed in [191-195].
Conclusion
The complex linkages between cellular physiology and
the multiple steps in recombinant protein synthesis
makes the task of removing bottlenecks in this pathway
a difficult exercise. However we now have a wealth of in-
formation from transcriptomic, proteomic and metabo-
lomic studies on the cellular factors affecting this pathway
as well the changes in flux to this pathway due to the cel-
lular stress response. The data has been useful in rational
design of host cells with better expression capabilities.
Also the use of high throughput screening methods have
allowed us to, reverse engineer these desired phenotypes,
adding vastly to the repertoire of beneficial knock-ins and
knock-outs. With the development of tools for genome
scale engineering to generate multiple knock-ins and
knock-outs we can now study the synergistic response of
these changes which were earlier limited to one or two
modifications. These could lead to major improvements
in the design of host platform for high level recombinant
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